These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
138 related articles for article (PubMed ID: 6531044)
1. Absorption, distribution, and excretion of 8-methoxypsoralen in HRA/Skh mice. Muni IA; Schneider FH; Olsson TA; King M Natl Cancer Inst Monogr; 1984 Dec; 66():85-90. PubMed ID: 6531044 [TBL] [Abstract][Full Text] [Related]
2. Distribution and accumulation of radioactivity in mice following administration of 14C-8-MOP and 3H-8-MOP: an autoradiographic study. Wulf HC Photodermatol; 1984 Dec; 1(6):293-7. PubMed ID: 6533620 [TBL] [Abstract][Full Text] [Related]
3. Disposition of 8-methoxypsoralen in the rat: methodology for measurement, dose-dependent pharmacokinetics, tissue distribution and identification of metabolites. Mays DC; Rogers SL; Guiler RC; Sharp DE; Hecht SG; Staubus AE; Gerber N J Pharmacol Exp Ther; 1986 Feb; 236(2):364-73. PubMed ID: 3944766 [TBL] [Abstract][Full Text] [Related]
4. Toxicity of 8-methoxypsoralen, 5-methoxypsoralen, 3-carbethoxypsoralen, or 5-methylisopsoralen with ultraviolet radiation in the hairless (HRA/Skh) mouse. Dunnick JK; Forbes PD; Davies RE; Iverson WO Toxicol Appl Pharmacol; 1987 Jun; 89(1):73-80. PubMed ID: 3590190 [TBL] [Abstract][Full Text] [Related]
5. Tumors of the skin in the HRA/Skh mouse after treatment with 8-methoxypsoralen and UVA radiation. Dunnick JK; Forbes PD; Eustis SL; Hardisty JF; Goodman DG Fundam Appl Toxicol; 1991 Jan; 16(1):92-102. PubMed ID: 2019354 [TBL] [Abstract][Full Text] [Related]
6. Autoradiographic localization of 8-methoxypsoralen in psoriasis skin in vitro. Bertaux B; Dubertret L; Moreno G Acta Derm Venereol; 1981; 61(6):481-5. PubMed ID: 6177157 [TBL] [Abstract][Full Text] [Related]
7. Ocular effects of treatment with various psoralen derivatives and ultraviolet-A (UVA) radiation in HRA/Skh hairless mice. Barker FM; Dayhaw-Barker P; Forbes PD; Davies RE Acta Ophthalmol (Copenh); 1986 Aug; 64(4):471-8. PubMed ID: 3776510 [TBL] [Abstract][Full Text] [Related]
8. Effect on topical 5-methoxypsoralen on tumorigenesis induced in albino and pigmented hairless mouse skin by UV irradiation. Reeve VE; Greenoak GE; Boehm-Wilcox C; Canfield PJ; Gallagher CH J Photochem Photobiol B; 1990 May; 5(3-4):343-57. PubMed ID: 2115915 [TBL] [Abstract][Full Text] [Related]
9. Kinetics of [14C-5] 8-methoxypsoralen uptake by UVA irradiated and non-irradiated rabbit eye tissues. Malinin GI; Glew WB; Roberts WP; Nigra TP Res Commun Chem Pathol Pharmacol; 1981 May; 32(2):223-34. PubMed ID: 7244361 [TBL] [Abstract][Full Text] [Related]
10. NTP Toxicology and Carcinogenesis Studies of 1-Amino-2,4-Dibromoanthraquinone (CAS No. 81-49-2) in F344/N Rats and B6C3F1 Mice (Feed Studies). National Toxicology Program Natl Toxicol Program Tech Rep Ser; 1996 Aug; 383():1-370. PubMed ID: 12692653 [TBL] [Abstract][Full Text] [Related]
11. Detection and quantification of 8-methoxypsoralen-DNA adducts. Santella RM; Yang XY; DeLeo VA; Gasparro FP IARC Sci Publ; 1988; (89):333-40. PubMed ID: 3058601 [TBL] [Abstract][Full Text] [Related]
12. Oral administration of 5-methoxypsoralen affects the distribution and metabolism of 2-aminofluorene in Sprague-Dawley rats. Lee YM; Chen SF; Li YC; Lin SS; Chung JG In Vivo; 2002; 16(3):201-13. PubMed ID: 12182117 [TBL] [Abstract][Full Text] [Related]
13. Studies on 8-methoxypsoralen tolbutamide interactions in vitro and in vivo. Bevilacqua R; Baccichetti F; Gaion RM Farmaco; 1991 Apr; 46(4):579-92. PubMed ID: 1930554 [TBL] [Abstract][Full Text] [Related]
14. Bioavailability study of two different 8-methoxypsoralen (8-MOP) preparations in patients receiving PUVA therapy. Nørgaard M; Hueg B; Staberg B Photodermatol; 1985 Aug; 2(4):252-6. PubMed ID: 3903679 [TBL] [Abstract][Full Text] [Related]
15. Absorption, distribution, metabolism, and excretion of N,N-diethyl-M-toluamide in the rat. Schoenig GP; Hartnagel RE; Osimitz TG; Llanso S Drug Metab Dispos; 1996 Feb; 24(2):156-63. PubMed ID: 8742226 [TBL] [Abstract][Full Text] [Related]
16. Metabolism of the anti-psoriatic agent 5-methoxypsoralen in humans: comparison with rat and dog. John BA; Chasseaud LF; Wood SG; Forlot P Xenobiotica; 1992 Nov; 22(11):1339-51. PubMed ID: 1492426 [TBL] [Abstract][Full Text] [Related]
17. Psoralen and ultraviolet A effects on epidermal ornithine decarboxylase induction and DNA synthesis in the hairless mouse. Lowe NJ; Connor MJ; Cheong ES; Akopiantz P; Breeding JH Natl Cancer Inst Monogr; 1984 Dec; 66():73-6. PubMed ID: 6531042 [TBL] [Abstract][Full Text] [Related]
18. Concentration of 3H-8-methoxypsoralen and its metabolites in the rat lens and eye after a single oral administration. Wulf HC; Andreasen MP Invest Ophthalmol Vis Sci; 1982 Jan; 22(1):32-6. PubMed ID: 7056622 [TBL] [Abstract][Full Text] [Related]
19. Efficacy of 8-methoxypsoralen vs. 5-methoxypsoralen plus ultraviolet A therapy in patients with mycosis fungoides. Wackernagel A; Hofer A; Legat F; Kerl H; Wolf P Br J Dermatol; 2006 Mar; 154(3):519-23. PubMed ID: 16445785 [TBL] [Abstract][Full Text] [Related]
20. Pharmacokinetics and autoradiography of [3H] or [14C]stepholidine. Zhang ZD; Zhou CM; Jin GZ; Zhang X; Yang L Zhongguo Yao Li Xue Bao; 1990 Jul; 11(4):289-92. PubMed ID: 2104478 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]